Keytruda (pembrolizumab) - Merck (MSD)
Temovate (clobetasol propionate) - Novartis
Opdivo (nivolumab) - Ono Pharma, BMS
Avastin (bevacizumab) - Roche
Oncoral (irinotecan oral) - Ascelia
Lonsurf (trifluridine/tipiracil) - Servier, Otsuka
Vectibix (panitumumab) - Amgen, Takeda
Erbitux (cetuximab) - Eli Lilly, EMD Serono
Stivarga (regorafenib) - Bayer
https://www.targetedonc.com/view/the-expanding-continuum-of-care-in-metastatic-colorectal-cancer
 
May 14, 2020
 
Prev Next